Eli Lilly (LLY) reduced its fourth-quarter sales guidance by 5%, lowering expectations to $13.5 billion. This figure is $400 ...

Lilly’s decision to offer vials has also been seen as its way to combat the rise in compounding. Patients have been turning ...

Cobb County has filed a lawsuit accusing several major insulin manufacturers and pharmacy benefit managers (PBMs) of ...